All News
10
Everything
Huize pioneers DeepSeek integration in China’s insurance sector, revolutionizing consumer-facing insurance services for the AI era
February 21, 2025 06:00 ET
|
Huize Holding Limited
SHENZHEN, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance...
Florida Tech Announces New Vertex Innovation Hub, Executive Director
February 21, 2025 06:00 ET
|
Florida Institute of Technology
MELBOURNE, FLA., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Florida Tech is proud to announce a new, game-changing entry into the innovation economy—and a visionary new executive director to lead the...
GTA new home sales remain low in January – but with prices down and inventory up, buyers have a unique opportunity in the months ahead
February 21, 2025 06:00 ET
|
Building Industry and Land Development Association (BILD)
Toronto, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Greater Toronto Area, February 21, 2025 – Greater Toronto Area (GTA) new home sales stayed low in January, but with prices low and inventory steady, these...
Ilkka-konsernin tilinpäätöstiedote vuodelta 2024: Q4 liikevaihto, oikaistu oman toiminnan liikevoitto sekä osakekohtainen tulos paranivat
February 21, 2025 06:00 ET
|
Ilkka Oyj
Ilkka Oyj Tilinpäätöstiedote 21.2.2025, klo 13.00ILKKA-KONSERNIN TILINPÄÄTÖSTIEDOTE VUODELTA 2024: Q4 liikevaihto, oikaistu oman toiminnan liikevoitto sekä osakekohtainen tulos...
Notice to convene Annual General Meeting of Nilfisk Holding A/S
February 21, 2025 06:00 ET
|
Nilfisk Holding A/S
The Annual General Meeting of Nilfisk Holding A/S will be held on Wednesday March 19, 2025, at Comwell Copenhagen Portside, Alexandriagade 1, 2150 Copenhagen. Attached please find: • Invitation...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
February 21, 2025 06:00 ET
|
Alvotech
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
February 21, 2025 06:00 ET
|
Alvotech
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of...
Udtrækning pr. 1. maj 2025 (CK95)
February 21, 2025 06:00 ET
|
DLR Kredit A/S
I medfør af kapitalmarkedsloven § 24, oplyser DLR Kredit A/S hermed om udtrækninger (CK95) pr. fredag den 21. februar 2025. Oplysningerne fremgår af vedhæftede fil. Denne meddelelse er offentliggjort...
Udtrækning pr. 1. april 2025 (CK95)
February 21, 2025 06:00 ET
|
DLR Kredit A/S
I medfør af kapitalmarkedsloven § 24, oplyser DLR Kredit A/S hermed om udtrækninger (CK95) pr. fredag den 21. februar 2025. Oplysningerne fremgår af vedhæftede fil. Denne meddelelse er offentliggjort...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
February 21, 2025 06:00 ET
|
Teva Pharmaceutical Industries Ltd
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of...